Cargando…

Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19

Detalles Bibliográficos
Autores principales:	Leef, Chelsea, Horton, Codi, Lee, Tricia, Lee, Gerald, Tison, Katherine, Vickery, Brian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2022
Materias:	Clinical Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576059/ https://www.ncbi.nlm.nih.gov/pubmed/34763124 http://dx.doi.org/10.1016/j.jaip.2021.08.044

Ejemplares similares

Peanut Oral Immunotherapy: a Current Perspective
por: Patrawala, Meera, et al.
Publicado: (2020)

Peanut immunotherapy
por: Anagnostou, Katherine, et al.
Publicado: (2014)

Oral immunotherapy for peanut allergy: The pro argument
por: Chinthrajah, R. Sharon, et al.
Publicado: (2020)

Oral immunotherapy for peanut allergy: The con argument
por: Fiocchi, Alessandro, et al.
Publicado: (2020)

Peanut allergy: Beyond the oral immunotherapy plateau
por: Bruton, Kelly, et al.
Publicado: (2021)

Interpreting success or failure of peanut oral immunotherapy
por: Cao, Shijie, et al.
Publicado: (2022)

Transitioning peanut oral immunotherapy to clinical practice
por: Lazizi, S., et al.
Publicado: (2022)

Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023)

Peanut oral immunotherapy: current trends in clinical trials
por: Reinwald, Simone, et al.
Publicado: (2022)

Identification of goals and barriers to treatment from 92 consecutive consultations with families considering peanut oral immunotherapy
por: Blackman, Andrea C., et al.
Publicado: (2019)

Mouse strain differences in response to oral immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

Risk factors associated with safety of preschool peanut oral immunotherapy
por: Karunakaran, Duva, et al.
Publicado: (2023)

Optimal period for achieving sustained unresponsiveness in peanut oral immunotherapy
por: Yamashita, Kosei, et al.
Publicado: (2023)

Peanut Immunotherapy: Stepping Towards Desensitization for Peanut Allergy
por: Hsu, Joyce
Publicado: (2020)

Open‐label follow‐on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy
por: Fernandez‐Rivas, Montserrat, et al.
Publicado: (2021)

Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis
por: Shaker, Marcus, et al.
Publicado: (2019)

Peanut oral immunotherapy may improve health‐related quality of life among severe peanut allergic adolescents
por: Ödling, Maria, et al.
Publicado: (2023)

Effect of ketotifen premedication on adverse reactions during peanut oral immunotherapy
por: Jagdis, Amanda, et al.
Publicado: (2014)

Insights into Microbiome and Metabolic Signatures of Children Undergoing Peanut Oral Immunotherapy
por: Blackman, Andrea C., et al.
Publicado: (2022)

Home-Based Peanut Oral Immunotherapy for Low-Risk Peanut-Allergic Preschoolers During the COVID-19 Pandemic and Beyond
por: Chua, Gilbert T., et al.
Publicado: (2021)

Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age
por: O'Sullivan, Michael David, et al.
Publicado: (2023)

2078- Immunotherapy – 2078. Allergen-specific oral immunotherapy for peanut allergy: a Cochrane systematic review
por: Nurmatov, Ulugbek, et al.
Publicado: (2013)

Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial
por: Michaud, Elodie, et al.
Publicado: (2015)

Continuing Peanut Oral Immunotherapy via Telemedicine During the COVID-19 Pandemic
por: Schoonover, Anna, et al.
Publicado: (2021)

Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells
por: Monian, Brinda, et al.
Publicado: (2022)

Bronchial hyperresponsiveness and asthma during oral immunotherapy for egg or peanut allergy in children
por: Burman, Janne, et al.
Publicado: (2022)

Children and caregiver proxy quality of life from peanut oral immunotherapy trials
por: Galvin, Audrey Dunn, et al.
Publicado: (2022)

Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy
por: Bird, J. Andrew, et al.
Publicado: (2023)

Adjuvanted Immunotherapy Approaches for Peanut Allergy
por: Johnson-Weaver, Brandi T., et al.
Publicado: (2018)

HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic success
por: Kanchan, Kanika, et al.
Publicado: (2022)

Efficacy and safety of oral immunotherapy for peanut allergy: a pilot study in Singaporean children
por: Zhong, Youjia, et al.
Publicado: (2018)

A Practical, Stepwise Approach to Peanut Oral Immunotherapy in Clinical Practice: Benefits and Risks
por: Anagnostou, Aikaterini
Publicado: (2021)

Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice
por: Portnoy, Jay, et al.
Publicado: (2022)

Immune signatures predicting the clinical outcome of peanut oral immunotherapy: where we stand
por: Wanniang, Naphisabet, et al.
Publicado: (2023)

Limited effect of intramuscular epinephrine on cardiovascular parameters during peanut-induced anaphylaxis: An observational cohort study
por: Turner, Paul J., et al.
Publicado: (2021)

Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy
por: Cherkaoui, Sabrine, et al.
Publicado: (2015)

T cell specific and non specific tolerance mechanisms in peanut oil immunotherapy in peanut allergic subjects
por: Singh, Amit, et al.
Publicado: (2011)

A novel peanut allergoid is safe and effective in immunotherapy in a peanut allergy mouse model
por: Smit, J, et al.
Publicado: (2013)

The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
por: Vonk, Marlotte M., et al.
Publicado: (2017)

Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy
por: Wright, Benjamin L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fbeic7qps8bs9g2oj10a65u9bm